Autologous bone marrow transplantation in children with acute myeloblastic leukemia: Report from the Italian National Pediatric Registry (AIEOP-BMT).

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 59-62

  Vignetti, M ^a   Rondelli, R ^b   Locatelli, F ^c   Lanino, E ^d   Miniero, R ^e   Rossetti, F ^f   Meloni, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CHILD; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; INFANT; ITALY; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; ITALY; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0029804195     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Creutzig U et al. Improvement of treatment results in children acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood 1985; 65:298-304.
2. Nesbit ME, Woods WG. Therapy of acute myeloid leukemia in children. Leukemia 1992; 6 (suppl. 2): 31-35.
3. Barnett AK et al. The role of BMT in addition to intensive chemotherapy in AML in first CR: results of MRC-AMLlO trial. Blood 1994; 84 (suppl. 1): 252a.
4. Grier NC et al Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HiDaze. Leukemia 1992; 6 (suppl. 2): 48-51.
5. Meloni G et al. ABMT for children AML: Italian experience. Bone Marrow Transpl 1991; 7 (suppl. 3): 80-83.
6. Meloni G, de Fabritiis P, Petti MC, Mandelli F. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 1990;75: 2282-2285.
7. Tutschka PJ, et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
8. Bonetti F et al. Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen. Leukemia 1995; 9:570-575.
9. Phillips GL et al. Busulfan, cyclophosphamide, and melphalan as conditioning for autologous bone marrow transplantation in hematologic malignancy. J Clin Oncol 1991;1880-1888.
10. Tiedemann K, et al. Results of intensive therapy in childhood acute myeloid leukemia incorporating high dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 1993; 82:3730-3738.
11. Gorin NC, Dicke K, Lowenberg B. High dose therapy for acute myelocytic leukemia treatment strategy: What is the choice? Ann Oncol 1993: 4 (suppl. 1):S59-S80